Sana Biotechnology Inc - ESG Rating & Company Profile powered by AI
If you are employed by Sana Biotechnology Inc and you wish to licence your ESG aseessment, please get in touch. Detailed ESG assessment of Sana Biotechnology Inc can be reached by registering for free. This ESG assessment for Sana Biotechnology Inc represents its reporting of the UN Sustainable Development Goals.
Sana Biotechnology Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.6; made up of an environmental score of 2.3, social score of 3.0 and governance score of 5.0.
3.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1546 | Valens Company Inc | 3.7 | Medium |
| 1546 | X T L Biopharmaceuticals Ltd | 3.7 | Medium |
| 1575 | Sana Biotechnology Inc | 3.6 | Medium |
| 1575 | Biogaia AB | 3.6 | Medium |
| 1575 | Healios KK | 3.6 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Sana Biotechnology Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Sana Biotechnology Inc report the average age of the workforce?
Sign up for free to unlockDoes Sana Biotechnology Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Sana Biotechnology Inc offer flexible work?
Sign up for free to unlockDoes Sana Biotechnology Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sana Biotechnology Inc conduct supply chain audits?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sana Biotechnology Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose water use targets?
Sign up for free to unlockDoes Sana Biotechnology Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Sana Biotechnology Inc have a product recall in the last two years?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Sana Biotechnology Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sana Biotechnology Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose parental leave metrics?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sana Biotechnology Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sana Biotechnology Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sana Biotechnology Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose its waste policy?
Sign up for free to unlockDoes Sana Biotechnology Inc report according to TCFD requirements?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose energy use targets?
Sign up for free to unlockDoes Sana Biotechnology Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sana Biotechnology Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sana Biotechnology Inc
These potential risks are based on the size, segment and geographies of the company.
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus; and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is headquartered in Seattle, Washington.